Do you want to stop or seriously cut down your cannabis use? Has your cannabis use led to problems at work, school, or home? Do you live in the Baltimore area?
We are working on a Johns Hopkins-approved research study to evaluate the safety and therapeutic potential of psilocybin in people with Cannabis Use Disorder (CUD). This study will examine the impact of psilocybin treatment on cannabis use and related variables including mood, sleep, and craving.
Participants complete a 12-week course of study treatment including two psilocybin sessions, with follow-up assessments three and six months after the first psilocybin session. After four weekly preparatory meetings including a targeted cognitive behavioral therapy (CBT) intervention for CUD, participants will receive a moderately high dose (25mg) of psilocybin in week 5 of their 12-week counseling, and either another moderately high dose (25mg) or a high dose (35mg) in week 7.
If you are deemed eligible and wish to participate, the total amount of time that you may be involved in the study is up to 30 weeks. You will be asked to attend about two screening visits, about twelve weekly visits throughout the study and two follow up study visits.
Additionally, payments will be provided for completing the end-of-treatment meeting in week 12 and 3 and 6 month follow-up sessions. Participants will receive $50 per follow-up visit completed.
To see if you might be eligible to participate in this study, please click the arrow below to complete a screening survey.
Study #IRB00281685
Principal Investigator: Albert Garcia-Romeu, Ph.D.